COFCO Capital Holdings Co., Ltd. (002423.SZ)
CNY 12.68
(0.96%)
CNY 12.68
(0.96%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 3.34 Billion CNY | 15.75% |
| 2022 | 2.89 Billion CNY | -2.25% |
| 2021 | 2.95 Billion CNY | 15.5% |
| 2020 | 2.56 Billion CNY | 67.05% |
| 2019 | 1.53 Billion CNY | 1042.8% |
| 2018 | 134.22 Million CNY | -48.49% |
| 2017 | 260.59 Million CNY | -9.67% |
| 2016 | 288.5 Million CNY | 19.55% |
| 2015 | 241.33 Million CNY | 20.97% |
| 2014 | 199.5 Million CNY | 175.17% |
| 2013 | 72.5 Million CNY | -19.44% |
| 2012 | 90 Million CNY | -10.0% |
| 2011 | 100 Million CNY | 0.0% |
| 2010 | 100 Million CNY | 0.0% |
| 2009 | 100 Million CNY | 0.0% |
| 2008 | 100 Million CNY | 0.0% |
| 2007 | - CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 3.1 Billion CNY | 1.19% |
| 2024 Q2 | 3.09 Billion CNY | -0.45% |
| 2024 Q3 | 1.51 Billion CNY | -50.91% |
| 2023 Q2 | 2.91 Billion CNY | -0.41% |
| 2023 Q3 | 3.33 Billion CNY | 14.3% |
| 2023 FY | 3.34 Billion CNY | 15.75% |
| 2023 Q4 | 3.34 Billion CNY | 0.41% |
| 2023 Q1 | 2.92 Billion CNY | 1.26% |
| 2022 Q3 | 2.84 Billion CNY | -2.95% |
| 2022 FY | 2.89 Billion CNY | -2.25% |
| 2022 Q4 | 2.89 Billion CNY | 1.61% |
| 2022 Q2 | 2.93 Billion CNY | -5.72% |
| 2022 Q1 | 3.11 Billion CNY | 5.13% |
| 2021 FY | 2.95 Billion CNY | 15.5% |
| 2021 Q3 | 2.83 Billion CNY | -1.6% |
| 2021 Q1 | 2.91 Billion CNY | 13.87% |
| 2021 Q4 | 2.95 Billion CNY | 4.55% |
| 2021 Q2 | 2.87 Billion CNY | -1.41% |
| 2020 Q2 | 2.57 Billion CNY | 65.78% |
| 2020 Q4 | 2.56 Billion CNY | 1.29% |
| 2020 FY | 2.56 Billion CNY | 67.05% |
| 2020 Q1 | 1.55 Billion CNY | 1.28% |
| 2020 Q3 | 2.52 Billion CNY | -1.78% |
| 2019 FY | 1.53 Billion CNY | 1042.8% |
| 2019 Q3 | 1.51 Billion CNY | 0.0% |
| 2019 Q4 | 1.53 Billion CNY | 1.35% |
| 2019 Q2 | - CNY | 0.0% |
| 2019 Q1 | - CNY | -100.0% |
| 2018 Q4 | 134.22 Million CNY | 3.03% |
| 2018 Q1 | 272.42 Million CNY | 4.54% |
| 2018 FY | 134.22 Million CNY | -48.49% |
| 2018 Q3 | 130.27 Million CNY | 0.0% |
| 2018 Q2 | 130.27 Million CNY | -52.18% |
| 2017 Q2 | 294.7 Million CNY | 2.15% |
| 2017 Q3 | 300.86 Million CNY | 2.09% |
| 2017 Q4 | 260.59 Million CNY | -13.38% |
| 2017 Q1 | 288.5 Million CNY | 0.0% |
| 2017 FY | 260.59 Million CNY | -9.67% |
| 2016 Q4 | 288.5 Million CNY | -23.07% |
| 2016 FY | 288.5 Million CNY | 19.55% |
| 2016 Q2 | 375 Million CNY | 55.39% |
| 2016 Q3 | 375 Million CNY | 0.0% |
| 2016 Q1 | 241.33 Million CNY | 0.0% |
| 2015 Q2 | 197.33 Million CNY | -7.14% |
| 2015 FY | 241.33 Million CNY | 20.97% |
| 2015 Q4 | 241.33 Million CNY | 15.84% |
| 2015 Q3 | 208.33 Million CNY | 5.57% |
| 2015 Q1 | 212.5 Million CNY | 6.52% |
| 2014 Q2 | 57.5 Million CNY | -11.54% |
| 2014 Q4 | 199.5 Million CNY | 299.0% |
| 2014 FY | 199.5 Million CNY | 175.17% |
| 2014 Q1 | 65 Million CNY | -10.34% |
| 2014 Q3 | 50 Million CNY | -13.04% |
| 2013 Q2 | 87.5 Million CNY | -2.78% |
| 2013 Q1 | 90 Million CNY | 0.0% |
| 2013 Q4 | 72.5 Million CNY | -9.38% |
| 2013 FY | 72.5 Million CNY | -19.44% |
| 2013 Q3 | 80 Million CNY | -8.57% |
| 2012 Q1 | 100 Million CNY | 0.0% |
| 2012 Q2 | 190 Million CNY | 90.0% |
| 2012 Q3 | 190 Million CNY | 0.0% |
| 2012 Q4 | 90 Million CNY | -52.63% |
| 2012 FY | 90 Million CNY | -10.0% |
| 2011 Q1 | 100 Million CNY | 0.0% |
| 2011 FY | 100 Million CNY | 0.0% |
| 2011 Q4 | 100 Million CNY | 0.0% |
| 2011 Q3 | 100 Million CNY | 0.0% |
| 2011 Q2 | 100 Million CNY | 0.0% |
| 2010 FY | 100 Million CNY | 0.0% |
| 2010 Q1 | 100 Million CNY | 0.0% |
| 2010 Q3 | 100 Million CNY | 0.0% |
| 2010 Q4 | 100 Million CNY | 0.0% |
| 2010 Q2 | 100 Million CNY | 0.0% |
| 2009 Q4 | 100 Million CNY | 0.0% |
| 2009 FY | 100 Million CNY | 0.0% |
| 2008 FY | 100 Million CNY | 0.0% |
| 2007 FY | - CNY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Hubei Biocause Pharmaceutical Co., Ltd. | 7.17 Billion CNY | 53.302% |